• <SPAN style="font-size: 11.0pt; font-family: 'Arial',sans-serif;">Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting</SPAN>
• A 10-year fight for vision in a patient with recurrent uveal melanoma: a case report
• A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation
• A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma
• A Systematic Review and Meta-Analysis on the Diagnostic and Prognostic Values of (18)F-FDG PET in Uveal Melanoma and Its Hepatic Metastasis
• Advancing retinoblastoma detection based on binary arithmetic optimization and integrated features
• Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review
• An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy
• Analysis of uveal melanoma scRNA sequencing data identifies neoplastic-immune hybrid cells that exhibit metastatic potential
• Automated segmentation for early detection of uveal melanoma
• Bilateral Vitiligo-Like Depigmentation of Choroid and Retinal Pigment Epithelium Associated with Ipilimumab-Nivolumab Therapy for Metastatic Cutaneous Melanoma
• CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma
• Case Report: Longitudinal Evaluation and Treatment of a Melanoma-Associated Retinopathy Patient
• Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma
• CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells
• Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort
• Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting
• Circumscribed choroidal hemangioma and non-pigmented choroidal melanoma: clinical, instrumental and molecular genetic features
• Clinical Experience of Stereotactic Radiosurgery at a Linear Accelerator for Intraocular Melanoma Combined with Iridociliary Tumor Resection: A Case Report
• Comparison of 18 F-AlF-NOTA-PRGD2 and 18 F-FDG PET/CT Imaging in a Case of Primary Uveal Melanoma
• Comparison of 18F-AlF-NOTA-PRGD2 and 18F-FDG PET/CT Imaging in a Case of Primary Uveal Melanoma
• Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model
• Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma
• Correction Method for Optical Scaling of Fundoscopy Images: Development, Validation, and First Implementation
• CyberKnife Stereotactic Radiosurgery for Uveal Melanoma: First Case Series in Central America
• Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
• Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
• Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
• Development of a prognostic risk model of uveal melanoma based on N7-methylguanosine-related regulators
• Diode laser ablation of progressive pigmented iris lesions in 317 cats (356 eyes) appears overall safe and effective in decreasing progression of iris pigmentation
• Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma
• Disrupting the Repeat Domain of Premelanosome Protein (PMEL) Produces Dysamyloidosis and Dystrophic Ocular Pigment Reflective of Pigmentary Glaucoma
• Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations
• Equivalent uniform RBE-weighted dose in eye plaque brachytherapy
• Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
• Extended survival in a case of metastatic choroidal melanoma with immunotherapy
• Extensive intraocular melanoma with secondary glaucoma in a 15-month-old Thoroughbred filly
• Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications
• Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma
• Hypotony and Anterior Uveitis following Dual Therapy with Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report
• Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases
• Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
• Importance of multimodal imaging diagnostics in acute angle closure glaucoma: Case report
• In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma
• Inhibition of cGAS-STING pathway alleviates neuroinflammation-induced retinal ganglion cell death after ischemia/reperfusion injury
• Intraocular schwannoma: case series of 28 patients and literature review
• Intraocular tumours imaging with transpalpebral near-infrared LED transillumination: Pilot study
• Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma
• Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells
• Large choroidal tuberculoma simulating a choroidal melanoma as the first manifestation of disseminated tuberculosis
• Leiomyoma - Ciliary Body Tumor. A Case Report
• Machine Learning Methods for Gene Selection in Uveal Melanoma
• Malignancies with a tendency to metastasize to the eyelid or ocular structures
• Measurements regarding a combined therapy concept for ophthalmic tumors consisting of brachytherapy and x-rays
• Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment
• Multiple neoplasms in patients with uveal melanoma: a systematic review
• New immunotherapy approaches as the most effective treatment for uveal melanoma
• New Treatment Horizons in Uveal and Cutaneous Melanoma
• Novel intraocular shielding device for eye plaque brachytherapy using magnetite nanoparticles: A proof-of-concept study using radiochromic film and Monte Carlo simulations
• Ocular and orbital tumors in childhood
• Ocular Melanoma
• Outcome of combined cataract surgery and iris prosthesis implantation in iris melanoma patients previously treated with iridocyclectomy: A national retrospective non-comparative case series
• Pathological and Molecular Diagnosis of Uveal Melanoma
• Pathological findings in enucleated eyes of patients with neurofibromatosis type 1: report of a case with 15-year follow-up and review of 14 patients in the literature
• Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
• Personalized treatment approaches in intraocular cancer
• Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses
• Proton Therapy for Ocular Melanoma: A Dosimetric Comparison of Three Different Delivery Systems
• Psychometric Results of a New Patient-Reported Outcome Measure for Uveal Melanoma Post-Brachytherapy Treatment: The PROM-UM
• Radiation Maculopathy in Patients with Malignant Melanoma of the Corpus Ciliare and Choroidea Following One-Day Session of Stereotactic Radiosurgery
• Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options
• Radiation-Induced Acquired Lacrimal Drainage Obstructions: Management and Outcomes
• Recent approaches for the treatment of uveal melanoma: Opportunities and challenges
• Role of microglia/macrophage polarisation in intraocular diseases (Review)
• Ruthenium brachytherapy for iris melanoma
• Senescent endothelial cells promote liver metastasis of uveal melanoma in single-cell resolution
• Single-cell characterization of macrophages in uveal melanoma uncovers transcriptionally heterogeneous subsets conferring poor prognosis and aggressive behavior
• Stereotactic radiotherapy for uveal melanoma: A case report
• STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling
• Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies
• Targeted therapy in ophthalmic oncology: The current status
• Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
• The Chick Chorioallantoic Membrane as a Xenograft Model for the Quantitative Analysis of Uveal Melanoma Metastasis in Multiple Organs
• The importance of ultrasound-guided biopsy: lesson from a case of liver metastasis from uveal melanoma
• The multiple roles of autophagy in uveal melanoma and the microenvironment
• The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms
• Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period
• Tryptophan metabolism-related gene expression patterns: unveiling prognostic insights and immune landscapes in uveal melanoma
• Tumor Control Probability and Time-Dose Response Modeling for Stereotactic Radiosurgery of Uveal Melanoma
• Ultrasensitive detection of uveal melanoma using [(18)F]AlF-NOTA-PRGD2 PET imaging
• Understanding choroidal nevus risk factors for transformation into melanoma
• Unilateral acute iris transillumination syndrome with glaucoma and iris pigment epithelium dispersion simulating iris melanoma
• Unusual Presentation of Unilateral Choroidal Melanoma with Bilateral Vasculitis in Young Individual: A Case Report and Review of Literature
• Updates in the Management of Uveal Melanoma
• Using Electronic Health Record Data to Determine the Safety of Aqueous Humor Liquid Biopsies for Molecular Analyses
• Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism
• Uveal melanoma: Current evidence on prognosis, treatment and potential developments
• Uveal melanoma: Recent advances in immunotherapy
• VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report
• Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma